INDIA MISSES ITS 2025 TARGET FOR TB ELIMINATION

23 Nov 2026

Tags: Social Justice   Social Services   Health sector issues

Source: The Hindu

Context: According to the WHO Global Tuberculosis Report 2026 (released November 12, 2026), India continues to account for nearly one-fourth of global TB cases and has missed its national target of eliminating TB by 2025, despite improvements in diagnosis and treatment.

India's Target for TB Elimination

  • National Target: Eliminate TB by 2025, five years ahead of the global SDG deadline of 2030, under the National Strategic Plan for TB Elimination (2017–2025).
  • National Targets (compared with 2015):
    • TB incidence: 80% reduction, from 217 to 43 cases per lakh population.
    • TB mortality: 90% reduction, from 32 to 3 deaths per lakh population.
    • Financial Protection: No family affected by TB should face catastrophic expenditure due to the disease.
  • WHO End TB Strategy: By 2025, aimed at reducing TB incidence by 50% and mortality by 75%, compared with 2015.

India's Progress: 2025 Status

  • TB Mortality: Declined by 38%, from 28 deaths per lakh population (2015) to 18 (2025). This achieved the WHO's 2020 milestone of 35% reduction, but five years late.
  • TB Incidence: WHO's 2025 report estimated a decline from 237 cases per lakh (2015) to 187 (2024), a reduction of approximately 21%, far below India's 80% target.
  • Case Notification: India diagnosed and notified 25.3 lakh TB cases in 2025.
  • Diagnostic Improvement: 46% of diagnosed cases were initially tested using rapid diagnostic tests in 2025, compared with 38% in 2024.
  • Latest Incidence Data: WHO has withheld India's 2025 incidence estimate pending assessment of new surveillance data.

IMPORTANT DATA DISTINCTION

The National Strategic Plan used a 2015 incidence baseline of 217 cases per lakh, whereas WHO's revised estimate is 237 cases per lakh. These belong to different estimation contexts and should not be treated as one continuous data series.

Why Has India Missed Its TB Elimination Target?

  • Undetected Cases: Delayed diagnosis, inadequate screening and failure to link patients to treatment allow continued transmission, particularly in remote and vulnerable communities.
  • Private Sector Challenges: A substantial number of patients seek private healthcare, making complete case notification and continuity of treatment difficult.
  • Unequal Access to Diagnosis: Access to testing, follow-up and appropriate treatment remains uneven.
  • Socio-economic Factors: Undernutrition increases susceptibility to active TB, while overcrowding and poor ventilation facilitate transmission.
  • Catastrophic Expenditure: Despite free medicines in public facilities, patients incur expenses on travel, investigations, nutrition and lost wages, affecting treatment adherence.
  • Drug-resistant TB: Resistance to TB medicines complicates treatment and increases the challenges of disease control.

Measures to Strengthen TB Diagnosis and Treatment

  • TB Mukt Bharat Abhiyaan: Promotes active case-finding and expanded screening to identify undiagnosed patients.
  • Rapid Molecular Diagnostics: Increased use of rapid diagnostic tests helps detect TB earlier and supports timely treatment.
  • BPaLM Regimen: A six-month, shorter all-oral treatment regimen combining Bedaquiline, Pretomanid, Linezolid and Moxifloxacin, for eligible patients with multidrug- or rifampicin-resistant TB.
  • Treatment Continuity: Early identification of drug resistance and timely linkage to appropriate treatment remain essential.

Why Has WHO Withheld India's 2025 TB Incidence Estimate?

  • Reason: WHO is assessing data from a new district-level sentinel surveillance exercise before publishing the revised estimate.
  • Coverage: Population-level surveillance across 50 representative districts.
  • Data Collection: First round completed in 2025; findings are being examined alongside the 2020–21 National TB Prevalence Survey.
  • Expected Release: Updated incidence estimates are expected in early 2027.
  • Significance: Data comparability and validation are necessary before revising national TB burden estimates.

Important Concepts for Prelims

TermMeaning
IncidenceNumber of new cases occurring in a population during a specified period.
PrevalenceTotal existing cases in a population at a particular time or during a defined period.
Case NotificationNumber of diagnosed TB cases reported to the health system.
Catastrophic Health ExpenditureHealth-related spending that severely affects a household's ability to meet its basic needs.
Drug-resistant TBTB caused by bacteria resistant to one or more anti-TB medicines.

Note: Case notifications do not represent the total number of people who developed TB. The difference between estimated incidence and notifications helps identify gaps in diagnosis and reporting, but does not directly equal the number of undiagnosed cases.

Way Forward

  • Strengthen Active Case-Finding: Expand screening and rapid molecular testing, particularly among vulnerable and remote populations.
  • Improve Private Sector Engagement: Ensure timely notification, standardised treatment and follow-up across public and private healthcare.
  • Address Social Determinants: Tackle undernutrition, overcrowding and poor living conditions that contribute to TB transmission.
  • Financial Protection: Strengthen nutritional and financial support to prevent treatment interruption and catastrophic expenditure.
  • Drug Resistance Management: Expand drug-susceptibility testing and access to shorter, effective treatment regimens.
  • Evidence-based Planning: Use updated surveillance data to revise targets and strengthen district-level interventions.

Prelims Question

Q1. With reference to tuberculosis (TB) burden estimation and India's efforts towards its elimination, consider the following statements:

  1. TB incidence refers to the total number of existing TB cases in a population at a particular point in time.
  2. The number of TB cases notified to the health system may be lower than the estimated incidence of TB.
  3. An increase in TB case notifications necessarily indicates an increase in the actual incidence of the disease.
  4. Changes in surveillance methodology may require revision of previously estimated disease burden to ensure data comparability.

Which of the statements given above are correct?

(a) 1 and 2 only
(b) 2 and 4 only
(c) 1, 3 and 4 only
(d) 2, 3 and 4 only

Answer: (b) 

Explanation:

  • Statement 1 is Incorrect: This describes prevalence. Incidence refers to new cases occurring during a specified period.
  • Statement 2 is Correct: Some patients remain undiagnosed or their cases are not notified, resulting in notifications being lower than estimated incidence.
  • Statement 3 is Incorrect: Increased notifications may result from improved screening, diagnosis and reporting rather than an actual increase in disease incidence.
  • Statement 4 is Correct: Revised surveillance methods and additional population-level data may necessitate recalibration of disease estimates.